These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1527658)
1. Crystal methamphetamine abuse: a concern to oral and maxillofacial surgeons. Lee CY; Heffez LB; Mohammadi H J Oral Maxillofac Surg; 1992 Oct; 50(10):1052-4. PubMed ID: 1527658 [TBL] [Abstract][Full Text] [Related]
2. Methamphetamine. Stimulant of the 1990s? Derlet RW; Heischober B West J Med; 1990 Dec; 153(6):625-8. PubMed ID: 2293467 [TBL] [Abstract][Full Text] [Related]
3. Risperidone treatment of methamphetamine psychosis. Misra L; Kofoed L Am J Psychiatry; 1997 Aug; 154(8):1170. PubMed ID: 9247413 [No Abstract] [Full Text] [Related]
4. [Current data on methamphetamine]. Cottencin O; Rolland B; Guardia D; Karila L Rev Prat; 2012 May; 62(5):679-81. PubMed ID: 22730802 [TBL] [Abstract][Full Text] [Related]
5. Methamphetamine-associated obsessional symptoms and effective risperidone treatment: a case report. Iyo M; Sekine Y; Matsunaga T; Tsukamoto T; Takei N; Mori N J Clin Psychiatry; 1999 May; 60(5):337-8. PubMed ID: 10362445 [No Abstract] [Full Text] [Related]
6. An analysis of 310 cases of acute high-dose methamphetamine toxicity in Haight-Ashbury. Smith DE; Fischer CM Clin Toxicol; 1970 Mar; 3(1):117-24. PubMed ID: 5520384 [No Abstract] [Full Text] [Related]
9. Cardiovascular effects of methamphetamine. Lynch J; House MA J Cardiovasc Nurs; 1992 Jan; 6(2):12-8. PubMed ID: 1729423 [TBL] [Abstract][Full Text] [Related]
10. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Sekine Y; Iyo M; Ouchi Y; Matsunaga T; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Takei N; Mori N Am J Psychiatry; 2001 Aug; 158(8):1206-14. PubMed ID: 11481152 [TBL] [Abstract][Full Text] [Related]
11. Ice--a new drug of concern? Beebe DK; Walley EJ J Miss State Med Assoc; 1994 Aug; 35(8):225-7. PubMed ID: 7932687 [TBL] [Abstract][Full Text] [Related]
12. [Minocycline as a therapeutic drug for methamphetamine use disorders]. Hashimoto K Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):19-22. PubMed ID: 18411705 [TBL] [Abstract][Full Text] [Related]
13. Acute exacerbation of methamphetamine psychosis and lasting dopaminergic supersensitivity--a clinical survey. Sato M Psychopharmacol Bull; 1986; 22(3):751-6. PubMed ID: 3797580 [No Abstract] [Full Text] [Related]
14. Lithium therapy for cocaine-induced psychosis: a clinical perspective. Scott ME; Mullaly RW South Med J; 1981 Dec; 74(12):1475-7. PubMed ID: 7313740 [TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics of dappou herb use--disorder patients at the drug dependence clinic: a comparison with methamphetamine use-disorder patients]. Tanibuchi Y; Matsumoto T; Kobayashi O; Wada K Seishin Shinkeigaku Zasshi; 2013; 115(5):463-76. PubMed ID: 23855225 [TBL] [Abstract][Full Text] [Related]
17. Cardiomyopathy associated with the smoking of crystal methamphetamine. Hong R; Matsuyama E; Nur K JAMA; 1991 Mar; 265(9):1152-4. PubMed ID: 1996001 [TBL] [Abstract][Full Text] [Related]
18. DARK Side of Amphetamine and Analogues: Pharmacology, Syndromic Manifestation, and Management of Amphetamine Addiction. Baig AM ACS Chem Neurosci; 2018 Oct; 9(10):2299-2303. PubMed ID: 29671582 [TBL] [Abstract][Full Text] [Related]
19. Crystal methamphetamine-induced acute pulmonary edema: a case report. Nestor TA; Tamamoto WI; Kam TH; Schultz T Hawaii Med J; 1989 Nov; 48(11):457-8, 460. PubMed ID: 2592191 [TBL] [Abstract][Full Text] [Related]
20. Comparison of responses by neuropeptide systems in rat to the psychotropic drugs, methamphetamine, cocaine and PCP. Hanson GR; Midgley LP; Bush LG; Johnson M; Gibb JW NIDA Res Monogr; 1989; 95():348. PubMed ID: 2484267 [No Abstract] [Full Text] [Related] [Next] [New Search]